Inhibition of Isoniazid-Induced Expression of Mycobacterium tuberculosis Antigen 85 in Sputum: Potential Surrogate Marker in Tuberculosis Chemotherapy Trials
AUTOR(ES)
Wallis, Robert S.
FONTE
American Society for Microbiology
RESUMO
Mycobacterium tuberculosis antigen 85 is induced in vitro by isoniazid (INH); its sustained induction in sputum during tuberculosis (TB) therapy predicts relapse. In this trial, rifampin or rifalazil inhibited the induction of sputum antigen 85 by INH in a dose-dependent fashion. This approach may facilitate the evaluation of new TB drugs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90462Documentos Relacionados
- Isoniazid-Induced Transient High-Level Resistance in Mycobacterium tuberculosis
- Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
- Genetic Analysis of Susceptibility to Isoniazid-Induced Seizures in Mice
- Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis.
- Isoniazid Uptake in Relation to Growth Inhibition of Mycobacterium tuberculosis
